GlassScriptPhysician profile
Susan L Chambers
NPI 1881613701
$2,752.99
in general payments reported to CMS, 2019-2025
28 companies · $527 in 2025
The $527 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $251 · 2021: $444 · 2022: $607 · 2023: $373 · 2024: $280 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.21 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $603.99 | 2019-2023 | Qulipta |
| Organon LLC | $405.04 | 2021-2025 | Nexplanon, Nuvaring |
| Mayne Pharma Commercial LLC | $289.66 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $193.20 | 2019-2025 | |
| Astellas Pharma US INC | $171.40 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $151.04 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $132.76 | 2019 | |
| Minerva Surgical, INC | $122.42 | 2020-2021 | |
| Therapeuticsmd, INC. | $83.66 | 2019-2021 | |
| Avion Pharmaceuticals | $75.88 | 2019-2021 | |
| Shield Therapeutics INC | $73.17 | 2025 | |
| Amgen INC. | $60.83 | 2020-2023 | Prolia, Evenity |
| Sage Therapeutics, LLC | $45.55 | 2021-2024 | |
| Allergan, INC. | $42.79 | 2019-2020 | |
| Agile Therapeutics, INC. | $37.25 | 2021-2024 | Twirla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $37.15 | 2024-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $35.66 | 2020-2021 | |
| Millicent US INC | $28.08 | 2025 | Femlyv |
| Conmed Corporation | $27.08 | 2025 | Airseal |
| Dexcom, INC. | $23.72 | 2025 | Dexcom G6 Transmitter |
| Mylan Pharmaceuticals INC. | $20.20 | 2022 | |
| Intuitive Surgical, INC. | $14.83 | 2025 | |
| Pfizer INC. | $14.67 | 2025 | |
| Acessa Health INC. | $13.96 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.99 | 2019 | |
| Coopersurgical, INC. | $12.72 | 2020 | |
| Evofem Biosciences, INC. | $12.25 | 2021 | |
| Meditrina | $11.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.